Immunogenetics in pathogenesis of and protection against toxoplasmosis

Current Topics in Microbiology and Immunology

Volumn 219, Issue , 1996, Pages 95-112

  McLeod, R ^a,b,c   Johnson, J ^a   Estes, R ^a   Mack, D ^a,b  

^a MICHAEL REESE HOSPITAL   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGENITAL TOXOPLASMOSIS; DISEASE RESISTANCE; HOST PARASITE INTERACTION; HUMAN; IMMUNOGENETICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TOXOPLASMA GONDII;

TOXOPLASMA GONDII;

EID: 0029778228     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-51014-4_10     Document Type: Review

References (67)

1. Abbas AK, Lichtman AH. Pober JS (1991) Cellular and molecular immunology. Saunders, Philadelphia
2. Aosai F. Yang TH. Ueda M. Yano A (1994) Isolation of naturally processed peptides from a Toxoplasma gondii-infected human B lymphoma cell line that are recognized by cytotoxic T lymphocytes. J Parasitol 80 260-266
3. Beaman MH, Araujo FG, Remington JS (1994) Protective reconstitution of the SCID mouse against reactivation of toxoplasmic encephalitis. J Infect Dis 160:375-383
4. Blackwell J, Roberts CW, Alexander J (1993) Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H-2 congenic mice Parasite Immun 15:317-324
5. Blackwell JM, Roberts CW, Roach TI, Alexander J (1994) Influence of macrophage resistance gene LSH/ITy/Bcg (candidate NRamp on Toxoplasma gondii infection in mice) Clin Exp Immunol 97:107-112
6. Bodner JG, Marsh SGE, Albert ED, Bodmer WF, Dupont B, Erlich HD. Mach B. Mayr WR, Patnam P, Sasazuld T (1994) Nomenclature report: nomenclature for factors of the HLA system. Tissue Antigens 44:1-18
7. Bohne W, Heesemann J, Gross U (1994) Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun 62 1761-1767
8. Boyer K, McLeod R (1996) Toxoplasma gondii and Toxoplasmosis. In: Long S, Proeber C, Pickering, L (eds) Pediatric infectious diseases. Churchill Livingstone (in press)
9. + T cells determine cyst number in Toxoplasma gondii infection. J Immunol 145:3438-3441
10. Brown CR, McLeod R (1994) Mechanisms of survival of mice during acute and chronic T. gondii infection. Parasitol Today 10:290-292
11. Brown C, David C, Kahn SJ, McLeod R (1994) Effect of human MHC class I genes on outcome of T. gondii cyst formation. J Immunol 152:4537-4541
12. Brown CR, Hunter C, Estes R, Beckmann E, Forman J, David C, Remington JS, McLeod R (1995) Definitive identification of a gene that confers resistance against toxoplasmosis Immunology 85:419-429
13. Burke JM, Roberts CW, Hunter CA, Murray M, Alexander J (1994) Temporal differences in the expression of mRNA for IL-10 and IFN-γ in the brains and spleens of C57BL/10 mice infected with Toxoplasma gondii. Parasite immunol 15:305-314
14. Couvreur J, Desmonts G, Girre JY (1976) Congenital toxoplasmosis in twins, J Ped 69.235-240
15. Couvreur J, Thulliez P (1996) Toxoplasmose acquise à localisation oculaire ou neurologique - 49 cas Presse Med 25.438-442
16. Deckert-Schlüter, Albrecht S, Hof H, Wiestler OD, Schluïer D (1995) Dynamics of the intracerebral and splenic mRNA production in Toxoplasma gondii -resistant and -susceptible congenic strains of mice. Immunology 85:408-419
17. + cells as effectors of IFN-γ dependent immunity to Toxoplasma gondii in MHC class I deficient mice. J Exp Med 175:1465-1472
18. + lymphocytes. J Exp Med 180:985-994
19. Gazzinelli RT, Oswald IP, James SL, Sher A (1992) IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ activated macrophages. J Immunol 148:1792-1796
20. Gazzinelli RT, Denkers EY, Sher A (1993a) Host resistance to Toxoplasma gondii, a model for studying the selective induction of cell-mediated immunity by intracellular parasites. Infect Agents Dis 2:139-149
21. Gazzinelli RT, Eltoum I, Wynn TA, Sher A (1993b) Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation J Immunol 151:3672-3681
22. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Casper P, Trinchien G, Sher A (1994) Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 153:2533-2543
23. Gazzinelli RT, Wysocka M, Hieny S, Kersten T, Carrera L, Cheever A, Kuhn R, Müller W, Trinchieri G, Sher A (1996) In the absence of endogenous IL-10 mice acutely infected with Toxoplasma gondii succumb to a lethal immune response associated with increased synthesis of IL-12, IFN-γ and TNF-α. J. Immunol (in press)
24. Hill AVS, Elvin J, Willis AC, Aidoo M, Allsopp CE, Gotch FM, Gai XM, Takiguchi M, Greenwood BM, Townsend AR (1992) Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434-439
25. Hohfeld P. Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M (1994) Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain reaction test on amniotic fluid. N Engl J Med 331:695-699
26. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Apella E, Engelhard VH (1992) Characterization of peptides bound to the class I MHC molecule HLA-A2 by mass spectrometry Science 255:1261-1263
27. Hunter CA, Subauste CS, Van Cleave VH, Remington JS (1994) Production of IFN-γ by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor-α. Infect Immun 62:2818-2824
28. Jones TC, Erb P (1985) H-2 Complex-linked resistance in murine toxoplasmosis. J Inf Dis 151.739-740
29. Johnson LL (1994) Resistance to Toxoplasma gondii in mice infected as neonates or exposed in utero. Infect Immun 62:3075-3079
30. Kaufmann SHE (1994) Bacterial and protozoal infections in genetically disrupted mice. Curr Opin Immunol 5.518-525
31. Khan IA, Matsuura T, Kasper LH (1994) Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun 62:1639-1642
32. Luft BJ, Remington JS (1992) Toxoplasmic encephalitis in AIDS Clin Inf Dis 15:211-222
33. Lukachar AE, Yupo M, Carroll JP, Abromson-Leeman SR, Laning C, Darf ME, Benjamin T (1995) Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J Exp Med 151:1683-1692
34. Mack D, Estes RG, McLeod R (1996a) Toxoplasma gondii superantigen (manuscript in preparation)
35. Mack D, Johnson J, Estes R, David C, Grumet C, Terasaki P, McLeod R (1996b) Toxoplasmosis susceptibility genes (manuscript in preparation)
36. Marrack P, Kappler J (1994) Subversion of the immune system by pathogens. Cell 76:323-332
37. Marrack P, Kushnir E, Kappler J (1991) A naturally inherited superantigen encoded by a mammary tumour virus. Nature 349:524-526
38. McAuley J, Boyer K, Patel D, Mets M, Swisher C, Roizen N, Wolters C, Stein L, Stein M, Schey W, McLeod R (1994) Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clin lnf Dis 18:38-72
39. McCabe RE, Brooks RG, Dorfman RF, Remington JS (1987) Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy Rev Infect Dis 9:754-774
40. McLeod R, Cohen H, Estes R (1984) Immune response to ingested Toxoplasma: description of a mouse model of Toxoplasma acquired by ingestion. J Infect Dis 149:234-244
41. McLeod R, Frenkel JK, Estes RG, Mack DG, Eisenhauer P, Gibori G (1988) Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital Toxoplasma challenge J Immunol 140 1632-1637
42. McLeod R, Eisenhauer P, Mack DG, Filice G, Spitalny G (1989a) Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J. Immunol 142:3247-3255
43. McLeod R, Skamene E, Brown CR, Eisenhauer P, Mack D (1989b) Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of AXB/BXA recombinant inbred and B10 congenic mice. J Immunol 143:3031-3034
44. + T-lymphocytes and the INT-1 locus in protection against Toxoplasma gondii. In. Smith J (ed) Toxoplasmosis. NATO ASI Series H Cell Biology; vol. 78 Springer, Berlin,Heidelberg, New York, pp 131-151
45. McLeod R, Brown C, Mack D (1993b) Immunogenetics influence outcome of T, gondii infection Res Immunol Ann Inst Pasteur 144:61-66
46. McLeod R, Bushman E, Arbuckle D, Skamene E (1995) Immunogenetics in the analysis of resistance to intracellular pathogens. Curr Oprn Immunol 7.539-552
47. Mets M, Holfels E, McLeod R, and the Toxoplasmosis Study Group (1992) Ophthalmologic findings in congenital toxoplasmosis Invest Ophthal Vis Sci 33:4
48. Mets M, Holfels E, McLeod R and the Toxoplasmosis Study Group (1996) The eye manifestations of toxoplasmosis. Am J Ophthalmol (in press)
49. + T cells using an ELLISPOT assay J Immunol Method 181.45-54
50. Montoya G, Remington J (1995) Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin Inf Dis 20:781-789
51. Nadeau JH, Arbuckle LD. Skamene E (1995) Genetic dissection of inflammatory responses. J Inflamm 45 27-48
52. Paigen K (1995) A miracle enough: the power of mice Nature Med 1 :215-220
53. Pamer EG, Harty JT, Bevan PNJ (1991) Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 353:852-855
54. Remington JS, McLeod R, Desmonts G (1995) Congenital Toxoplasmosis, In, Remington JS, Klein J (eds) Infections of the fetus and newborn infant Saunders, Philadelphia, 140-268
55. Roberts CW, Cruickshank SM, Alexander J (1995) Sex determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production. Infect Immun 63:2549-2555
56. Roberts CW, Ferguson DJP, Jebban H, Satoskar A. Bluethmann H, Alexander J (1996) Different roles for IL4 during the course of Toxoplasma gondii infection. Infect Immun 64:897-904
57. Sher A, Oswald IP, Hieny S, Gazzinelli RT (1993) Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. J Immunol 150 3982-3989
58. Sibley DL, Adams LB, Fukutomi Y, Krahenbuhl JL (1991) Tumor necrosis factor-α triggers antitoxoplasmal activity of IFN-γ primed macrophages. J Immunol 147:2340-2345
59. Sibley DL, Boothroyd J (1992) Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359:82-85
60. Suzuki Y, Joh K (1994) Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to IFN-γ. Parasitol Res 80:125-130
61. Suzuki Y, Remington JS (1993) Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection. Infect Immun 61:2264-2288.
62. Suzuki Y, Conley F, Remington JS (1989) Differences in virulence and development of encephalitis during chronic infection vary with the strain of Toxoplasma gondii. J Infec Dis 159:790-793
63. Suzuki Y, John K, Orellana MA, Conley FK, Remington JS (1991) A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 74:732-739
64. Suzuki Y, Joh K, Kwon OC, Yang Q, Conley FK, Remington JS (1994) MHC class I gene(s) in the D/L region but not the TNF-α gene determines development of toxoplasmic encephalitis in mice J Immun 97:4649-4654
65. Townsend JJ, Wolinsky JS, Barringer JR, Johnson PC (1975) Acquired toxoplasmosis. Arch Neurol 32:335-343
66. Williams DM, Grumet FC, Remington JS (1978) Genetic control of murine resistance to Toxoplasma gondii. Infect Immun 9:416-420
67. Zanelli E, Gonzalez-Gay MA, David CS (1995) Could HLA-DRI be the protective locus in rheumatoid arthritis? Immunol Today 16 274-278